CA
BHVN icon

Continuum Advisory’s Biohaven BHVN Stock Holding History

Continuum Advisory’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729 Buy
+49
New +$527 ﹤0.01% 1887
2025
Q2 		– Sell
-30
Closed -$721 – 528
2025
Q1 		$721 Buy
+30
New +$1.06K ﹤0.01% 1550

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Continuum Advisory's BHVN Position: Q2 2026 in Review

Continuum Advisory opened a new position in Biohaven (BHVN) in Q2 2026: 49 shares worth $729. The stake represents ﹤0.01% of the portfolio and ranks #1887 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in BHVN as recently as Q1 2025.

Continuum Advisory first reported a position in BHVN in Q1 2025 and has held it in 2 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Continuum Advisory held 49 shares of Biohaven worth $729 as of Q2 2026.
  • Biohaven was a new Continuum Advisory position in Q2 2026.
  • Biohaven made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1887 holding.
  • Continuum Advisory first reported a position in Biohaven in Q1 2025 and has held it in 2 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.